Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001983025 | SCV002243903 | pathogenic | Anophthalmia-microphthalmia syndrome | 2023-10-13 | criteria provided, single submitter | clinical testing | A gross deletion of the genomic region encompassing the full coding sequence of the OTX2 gene has been identified. Loss-of-function variants in OTX2 are known to be pathogenic (PMID: 15846561, 20486942, 22577225, 24167467). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes. A similar copy number variant has been observed in individual(s) with autosomal dominant agnathia-otocephaly complex and microphthalmia, anophthalmia, coloboma spectrum (PMID: 24167467, 24498598). In at least one individual the variant was observed to be de novo. For these reasons, this variant has been classified as Pathogenic. |